BFV-86290-30747 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-12-08
Registered in v-safe
2021-12-08
Dose 1 — Pfizer-BioNTech
2021-12-08
Health check-in — day 0, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-12-11
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-12-17
Health check-in — day 7, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-12-23
Health check-in — day 14, dose 1, dependent
Feeling: Good

Adult check-in
2021-12-29
Dose 2 — Pfizer-BioNTech
2021-12-29
Health check-in — day 0, dose 2, dependent
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-30
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-01-02
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · Abdominal pain

Adult check-in
2022-01-08
Health check-in — day 7, dose 2, dependent
Feeling: Fair · Chills, Nausea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2022-01-12
Survey response — day 14, dose 2, dependent
MedDRA: Abdominal pain, Constipation, Emergency care — Feeling: Good · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Symptoms: Abdominal pain and severe constipation. · Healthcare visit (other): (b)(6) Hospital

MedDRA releases: 2024-11 · check-in free text available
2022-01-12
Report sent to call center — day 14, dose 2, dependent
Be unable to do their normal daily activities · Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · 1 call case(s)
2022-01-13
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-01-21
Health check-in — day 21, dose 2, dependent
Feeling: Good

Adult check-in
2022-12-29
Survey response — 12 months, dose 2, dependent
MedDRA: Lacrimation increased, Nasopharyngitis, Oropharyngeal pain — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Soar throat, watering eyes, cold symptoms.

MedDRA releases: 2024-11 · check-in free text available
2022-12-29
Report sent to call center — 12 months, dose 2, dependent
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-30
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-12-08	Pfizer-BioNTech	No
2	2021-12-29	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-01-12	Successful 2022-01-13	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-12-29	Unsuccessful

Free text

Release 10 — day 14, dose 2, dependent

2022-01-12

Symptoms: Abdominal pain and severe constipation.

Healthcare visit (other): (b)(6) Hospital

redacted (b)(6)

Release 12 — 12 months, dose 2, dependent

2022-12-29

Symptoms: Soar throat, watering eyes, cold symptoms.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Emergency care	·	·	✓
SD	Abdominal pain	·	·	✓
SD	Constipation	·	·	✓
SD	Lacrimation increased	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Oropharyngeal pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release